May 14, 2019 / 06:20PM GMT
Bob Hopkins - BofA Merrill Lynch - Analyst
So thanks, everybody, for being here. I am Bob Hopkins from Bank of America. This is the first session from a medical device perspective, so we are absolutely thrilled to have the senior management team from Alcon here today. Obviously I'd say newly traded, but it's really new for the third time back to the public markets for Alcon. And really from my perspective the feature presentation for me from a medtech perspective.
So we have a full team from the Company. Obviously Dave Endicott, the Company's CEO is here. Karen King, who is the Senior Vice President of Investor Relations and Communications, is here as well. And then Tim Stonesifer, the new Chief Financial Officer, is here as well.
And I should also give a shout out and thank you to Christina who works on Karen's team. A phenomenal set of resources that Alcon has developed for investors; definitely encourage everybody to take advantage of that great resource that's been created. So thank you, you guys, for being here.
So I wanted to -- in our time here today, to try and cover a
Alcon AG at Bank of America Merrill Lynch Health Care Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers